The scientist’s investigation covers issues in Virology, Simian immunodeficiency virus, Immunology, Cytotoxic T cell and Virus. His research in Virology intersects with topics in Epitope and CTL*, MHC class I, CD8. His Simian immunodeficiency virus research is multidisciplinary, incorporating perspectives in Immunodeficiency, Viremia, Viral load, Viral replication and Major histocompatibility complex.
His Immunology research incorporates elements of HIV vaccine, AIDS Vaccines and Macaque. His Cytotoxic T cell study incorporates themes from T lymphocyte and Antigen. His Virus research includes themes of Vaccinia, Immunodominance and Cellular immunity.
His scientific interests lie mostly in Virology, Simian immunodeficiency virus, Immunology, MHC class I and Major histocompatibility complex. His work deals with themes such as Epitope, Cytotoxic T cell and CD8, which intersect with Virology. His work carried out in the field of Simian immunodeficiency virus brings together such families of science as Macaque, HIV vaccine, AIDS Vaccines, CTL* and Lentivirus.
His Acquired immunodeficiency syndrome research extends to the thematically linked field of Immunology. His study in MHC class I is interdisciplinary in nature, drawing from both Peptide binding, Saguinus oedipus, Pseudogene and Rhesus macaque. The concepts of his Major histocompatibility complex study are interwoven with issues in Molecular biology and Nonsynonymous substitution.
David I. Watkins mostly deals with Virology, Simian immunodeficiency virus, Antibody, Virus and Immunology. His Virology study combines topics from a wide range of disciplines, such as CD8 and Immune system. His CD8 research incorporates themes from T cell, Epitope, Cytotoxic T cell, Major histocompatibility complex and Rhesus macaque.
His Simian immunodeficiency virus research includes elements of Heterologous, Viral vector, Vaccine efficacy and Group-specific antigen. His Virus research is multidisciplinary, relying on both Human leukocyte antigen, CTL*, Recombinant DNA and B cell. Specifically, his work in Immunology is concerned with the study of Vaccination.
Virology, Zika virus, Virus, Viral replication and Immunology are his primary areas of study. His Virology research integrates issues from Cytotoxic T cell and Antibody. David I. Watkins interconnects Epitope, Ex vivo and CD8 in the investigation of issues within Cytotoxic T cell.
His work on Simian immunodeficiency virus expands to the thematically related Viral replication. His biological study spans a wide range of topics, including Spleen, CTL* and Macaque. His research in Immunology is mostly concerned with Viral load.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.
Todd M. Allen;David H. O'Connor;Peicheng Jing;John L. Dzuris.
Nomenclature for the major histocompatibility complexes of different species: a proposal
Jan Klein;Jan Klein;Ronald E. Bontrop;Roger L. Dawkins;Henry A. Erlich.
HIV and SIV CTL escape: implications for vaccine design.
Philip J. R. Goulder;Philip J. R. Goulder;David I. Watkins.
Nature Reviews Immunology (2004)
Impact of MHC class I diversity on immune control of immunodeficiency virus replication
Philip J. R. Goulder;David I. Watkins.
Nature Reviews Immunology (2008)
Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers
Ann J. Hessell;Eva G. Rakasz;Pascal Poignard;Pascal Poignard;Lars Hangartner;Lars Hangartner.
PLOS Pathogens (2009)
Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen
Tomas Hanke;Rachel V. Samuel;Tom J. Blanchard;Veronica C. Neumann.
Journal of Virology (1999)
Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.
David T. Evans;David T. Evans;David H. O'Connor;Peicheng Jing;John L. Dzuris.
Nature Medicine (1999)
Reversion of CTL escape-variant immunodeficiency viruses in vivo.
Thomas C Friedrich;Elizabeth J Dodds;Levi J Yant;Lara Vojnov.
Nature Medicine (2004)
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
Brian Moldt;Eva G. Rakasz;Niccole Schultz;Po-Ying Chan-Hui.
Proceedings of the National Academy of Sciences of the United States of America (2012)
Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.
David H. O'Connor;Todd M. Allen;Thorsten U. Vogel;Peicheng Jing.
Nature Medicine (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: